OCTAGEN
Octagen Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of hemophilia and genetic disorders of the clotting process. It develops two variations of recombinant B domain deleted porcine factor VIII to avoid inactivation by flying below the radar screen of the immune system. The company was founded in 1997 and is based in Penn Valley, Pennsylvania. As of July 17, 2008, Octagen Corporation operates as a subsidiary of Ipsen S.A.
OCTAGEN
Industry:
Biotechnology
Founded:
1997-01-01
Address:
Narberth, Pennsylvania, United States
Country:
United States
Status:
Active
Similar Organizations
Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.
AnorMED
AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs.
Dyax
Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet
Current Employees Featured